All posts by medical

University Receives Nearly $28.4 Million in Grants During 2020-21 Fiscal Year | CSUF News – CSUF News

Cal State Fullerton faculty and staff were awarded nearly $28.4 million in grants during the 2020-21 fiscal year, marking the second highest level of annual grant funding in the universitys history.

The following are the $5.6 million in grants awarded in the fourth quarter of the past fiscal year. Supported projects ranged from monitoring living shorelines and exploring disengagement among Latinx adolescents during the COVID-19 pandemic to developing therapeutic strategies for the treatment of acute and chronic pain.

Michael Daniel, director of the Small Business Development Center: $2,631,339 from the U.S. Small Business Administration for the Orange County Inland Empire Small Business Development Center 2021 project

Sam Behseta, professor of mathematics: $583,900 from the U.S. Army for the project titled A Next Generation High-Performance Computing Cluster for Research and Teaching at a Primarily Undergraduate Hispanic-Serving Institution

Related: $600,000 Grant for Supercomputer to Boost Research, Teaching

Mark Ellis, professor of secondary education: $580,456 from the National Science Foundation for the project titled Advancing Teachers of Mathematics to Advance Learning for All

Archana McEligot, professor of public health: $374,647 from the National Institutes of Health for the project titled Neurocognitive Aging and Analytics Research Education

Amybeth Cohen, professor of biological science: $229,904 from the National Institutes of Health for the project titled Cal State Fullerton Maximizing Access to Research Careers Undergraduate Student Training for Academic Research

Related: MARC Program Graduates Prepared for Ph.D. Studies in Biomedical Science

Danielle Zacherl, professor of biological science: $197,868 in total funding

Stevan Pecic, assistant professor of chemistry and biochemistry: $142,000 from the National Institutes of Health for the project titled Development of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors as a Promising Therapeutic Strategy for the Treatment of Acute and Chronic Pain

Related: Biochemist Seeks New Drug Treatment for COVID-19 Patients

Laura Gil-Trejo, director of the Social Science Research Center: $131,298 in total funding

Niroshika Keppetipola, associate professor of chemistry and biochemistry: $106,500 from the National Institutes of Health for the project titled Role of Phosphorylation in RNA Binding Protein Function

Joshua Yang, professor of public health: $99,988 from The Regents of the University of California Office of the President for the A Digital Mixed Methods Evaluation of University Tobacco-Free Policies project

Yinfei Kong, associate professor of information systems and decision sciences: $90,264 in continuing funding from National Institutes of Health via the University of Chicago for the Gender Disparities in Access and Engagement in Medication-Assisted Treatment for Opioid Use Disorder project

Related: Titan Data Scientist to Study Gender Differences in Opioid Treatment

Adriana Badillo, director of the Center for Research on Educational Access and Leadership: $76,621 from the city of Anaheim for the Anaheim Public Utilities College Internship Program project

Brady Heiner, executive director of the California State University Project Rebound Consortium: $30,000 from the CSU Project Rebound Connection for the Food Justice Initiative project

Joyce Gomez-Najarro, assistant professor of literacy and reading education: $59,956 from the Spencer Foundation for the project titled Preparing Teacher Candidates to Foster Deeper Learning Through Inclusive Practices; A Case Study of One Exemplary Dual Licensure

Guadalupe Espinoza, associate professor of child and adolescent studies: $35,000 from the Society for Research on Adolescence for the project titled School (Dis)Engagement Among Latino Adolescents During the COVID-19 Pandemic: A Mixed Methods Study

Dawn Person, director of the Center for Research on Educational Access and Leadership: $30,000 from the Coast Community College District for the Coast Community College District Climate Study project

Phillip Gedalanga, assistant professor of public health: $29,998 from the South Orange County Wastewater Authority for the project titled Application and Validation of Microbial Source Tracking Biomarkers to Differentiate Viable and Nonviable Targets of Human Fecal Pollution in Natural and Engineered Environments Throughout South Orange County

Marcelo Tolmasky, professor of biological science: $25,877 from the National Institutes of Health for the Los Angeles Basin-California State University Minority Health and Health Disparities Research Training Program project

Related: Students Study HIV, Novel Cancer Treatments at Foreign Universities

Alfonso Agnew, chair and professor of mathematics: $25,319 from the Trustees of the California State University for the project titled Early Start STEM Early Einstein Program

Valerie Poynor, assistant professor of mathematics: $21,775 from the U.S. Department of Education via Los Angeles City College for the STEM Pathways Program project

Daniel Cavagnaro, director of the Decision Research Center and lecturer in information systems and decision sciences: $17,795 from the National Science Foundation via the Board of Trustees of the University of Illinois for the Advances in Behavioral Decision Analytics: Theory Applications and Training project

Juye Ji, associate professor of social work: $17,137 from the National Institutes of Health via the Kaiser Foundation Research Institute for the project titled Linking DNA Methylation with Child Maltreatment and Mental Health Across Adolescence

Natalie Fousekis, director of the The Lawrence de Graaf Center for Oral and Public History and professor of history: $12,834 from the California Secretary of State for the project titled The California State Library Archives Oral History Project

David Gerkens, professor of psychology: $1,500 from the Psi Chi International Honor Society in Psychology for the project titled How User Comments Affect Peoples Agreement with Posts About Global Warming: A Replication and Expansion of Lewandowsky

View original post here:
University Receives Nearly $28.4 Million in Grants During 2020-21 Fiscal Year | CSUF News - CSUF News

UAH second university in Southeast to have specialized atmospheric spectrometer – UAH News

Dr. Shanhu Lee, an associate professor of atmospheric science, received a National Science Foundation grant for the instrument.

Michael Mercier | UAH

In the spring, the University of Alabama in Huntsville (UAH) Department of Atmospheric and Earth Science will become the home base for a new instrument designed to help scientists study aerosols in the atmosphere.

UAH, a part of the University of Alabama System, will become only the second university in the Southeast to have this special type of spectrometer, joining Georgia Tech.

The instruments name is a mouthful the Filter Inlet for Gases and Aerosols High-Resolution Time-of-Flight Chemical Ionization Mass Spectrometer. It will be shared by UAH and three partner universities.

Dr. Shanhu Lee, an associate professor of atmospheric science, received a $349,000 National Science Foundation (NSF) Major Research Instrumentation (MRI) grant to acquire the instrument for real-time molecular level measurement of atmospheric gas- and particle-phase compounds. The UAH Earth System Science Center is providing $149,760 as the institutional cost share.

The spectrometer will be used for atmospheric aerosol research at UAH and shared with Dr. Amanda Frossard, assistant professor of chemistry at the University of Georgia; Dr. Charles Stainer, professor of chemical and biochemical engineering at the University of Iowa; and Dr. Murray Johnston, associate dean of arts and sciences and professor of chemistry and biochemistry at the University of Delaware. Other users may be added in the future.

This is a field-deployable instrument, which means this instrument is easily shipped to different locations, says Dr. Lee.

This instrument does two unique things, she says. One is to measure chemical composition of small clusters either electrically charged or neutral formed in the atmosphere. Second is to measure chemical composition of aerosol- and gas-phase species, simultaneously.

The instrument is useful for atmospheric research related to aerosol formation and growth, and aerosol chemistry, Dr. Lee says. Atmospheric aerosols are also known as particulate matter, a suspension of fine solid particles or liquid droplets in the air that originate from natural and human activity sources.

The main reason behind this research is to understand the aerosol effects on global climate, air quality and human health, says Dr. Lee. My group is conducting new particle formation studies via laboratory observations and filed observations. We want to know how naturally emitted vs. pollutant trace gases are oxidized in the atmosphere to form aerosol particles.

The spectrometer will provide the important chemical fingerprints of chemical compounds that play critical roles in the new particle formation processes.

There may be some co-effects, either enhancing or suppressing, when we mix different chemical compounds emitted from different sources, she says. Understanding these mixing effects will help to better predict cloud production, because in the real atmosphere, we always have many different types of chemical compounds mixed together as opposed to homogeneous compounds and they constantly evolve through chemical reactions.

The NSFs MRI program encourages proposals with multiple users, so Dr. Lee coordinated the partnership between UAH and the other three universities by teaming with colleagues who could benefit.

For a shared user, this is a great deal, better than buying an expensive one on their own, Dr. Lee says. This instrument belongs to UAH, but it will be shipped to them and rotated among different users.

Each user group will be responsible for their own operation, troubleshooting and maintenance at their site.

It is like we have continuous field campaigns, where the instrument is shipped to different locations, she says. I hope this instrument will open new collaborations between shared users.

Original post:
UAH second university in Southeast to have specialized atmospheric spectrometer - UAH News

Theileriosis in goats – The Nation

There are 25 goat breeds in Pakistan. Beetal, Kamori, Nachi, Dera Din Panah, Angora and Teddy are the most prevalent domestic breeds and there are two wild breeds such as Ibex and Markhor. Goats are prone to parasitism which results in the form of reduced reproduction, more susceptibility to secondary infections and increased mortality.

The hemiparasites including babesia, theileria, trypanosoma and anaplasma etc. cause high morbidity and mortality due to increased prevalence. Theileriosis is a significant tick-borne, blood protozoan disease of small ruminants. The only two etiological agents of theileriosis in goats are theileria ovis and theileria lestoquardi in Pakistan. The clinical signs that are observed in goats suffering from theileriosis are increased body temperature, swollen lymph nodes, pale mucous membrane, anorexia, loss of weight, constipation and diarrhoea etc.

When a tick bites an animal, sporozoites invade the host body, it is transformed into schizonts in lymphocytes. The infected lymphocytes are transformed into lymphoblasts which continue to proliferate synchronously along with the schizonts. Eventually the infected daughter lymphoblasts are spread throughout the lymphatic system and continue to proliferate. The haematological analysis also showed a significant rise in leukocyte count in infected goats which may be due to the proliferation of lymphoblsts as a defensive response to invading parasites. In the later stages of theileriosis, the schizonts transformed to merozoites are released by the lymphoblasts and they invade erythrocytes. At this stage, they are called piroplasms. At this stage, there is excessive destruction of red blood cells that leads to anaemia.

Blood and urine samples were obtained from 20 theileria positive and 20 normal goats from different farms of Lahore. The infected goats showed clinical signs associated with theileriosis. Haematology, serum biochemistry and urinalysis by dipstick method were performed to observe the alterations in renal function and urine characteristics and results were compared with the reference values for goats. On performing CBC, serum biochemistry and urinalysis by dipstick method, we observed significant deviations from the reference values. A significant increase in Total Leukocyte Count was seen while there was a significant decline in Total Erythrocyte Count, Hb level and Packed Cell Volume was observed when CBC was performed. When renal function tests i.e. creatinine and Blood Urea Nitrogen were performed, a significant rise in their values was observed. Urinalysis by dipstick method also showed some deviations from the reference values.

Sadaf Gul, Dr. Qamar-un-Nisa,

Lahore.

Visit link:
Theileriosis in goats - The Nation

Dibutyl Itaconate (Cas 2155-60-4) Market 2021 Global Future Growth, Leading Players and Forecast to 2027| HANERCHEM, Zhejiang Guoguang Biochemistry,…

Dibutyl Itaconate (Cas 2155-60-4)-market

Report Overview (2021-2027)

United States:AlgoroReports shared a latestmarket report on the Dibutyl Itaconate (Cas 2155-60-4) market is published to provide the overall analysis of the Dibutyl Itaconate (Cas 2155-60-4) market. The Report consists of information such as market value, market share, market revenue, and the capacity of the market. The report provides historical market values for the period 2021, along with the market value for the upcoming year 2027. The report also consists of information about the market capacity of the various companies that are present at the global and regional levels. The rising CAGR percentage is also mentioned in the Dibutyl Itaconate (Cas 2155-60-4) market report for the forecast period 2021-2027. The report highlights the future growth of the Dibutyl Itaconate (Cas 2155-60-4) market at global, regional, and company levels.

Top Key Players/ Manufacturers in the Dibutyl Itaconate (Cas 2155-60-4)Market:

HANERCHEM, Zhejiang Guoguang Biochemistry, ESIM Chemicals, Qingdao Kehai Biochemistry, MP Biochemical

GetLatest Sample Copy ofthis Report:https://www.algororeports.com/sample-request/dibutyl-itaconate-cas-2155-60-4-market-research-report-trends-two-3119097

Note: The final report will add the analysis of the Impact of Covid-19 in this report industry.

Market Dynamics

Even the smallest factors are sometimes responsible for changing the dynamics of the Dibutyl Itaconate (Cas 2155-60-4) market. The report provides information on key market trends and changing customer choices. These two factors are always depended on each other, the change in the customer choices can directly affect the market trends. The market trends are always decided based on customer choices. The other factors that are responsible for causing changes in the market scenario have been precisely analysed in the market report. The Dibutyl Itaconate (Cas 2155-60-4) market report provides information about the production and apparent consumption in the Dibutyl Itaconate (Cas 2155-60-4) market. The non-economic factors also play the main role in causing a change in the dynamics of the Dibutyl Itaconate (Cas 2155-60-4) market. The report provides data about the various challenges that are faced by the market players operating in the Dibutyl Itaconate (Cas 2155-60-4) market. The whole market has been analysed at regional, global, and company levels.

This report segments the market on the basis of Types are:

Ester content 97%Ester content 97%

On the basis of Application, the market is segmented into:

PlasticizerCrosslinker

Segmentation

The report incorporates the different portions the Dibutyl Itaconate (Cas 2155-60-4) market is separated into. This incorporates item classifications, income age openings from these items, and customer drifts that drive the item interest. Topographical division of the market coversNorth America, Latin America, Europe, and the Asia Pacific area, essentially. The critical focal point of the investigation that structures a reason for the division is to achieve exhaustive and viable bits of knowledge into the Dibutyl Itaconate (Cas 2155-60-4) market.

Hurry Up! Enquiry & Get amazingDiscount to this Report: https://www.algororeports.com/check-discount/dibutyl-itaconate-cas-2155-60-4-market-research-report-trends-two-3119097

Research Methodology

The market experts have analyzed the historical data of the Dibutyl Itaconate (Cas 2155-60-4) market along with the future aspects to provide the overall market size of the Dibutyl Itaconate (Cas 2155-60-4) market in the market report. The tools such as Porters Five Force Model have been used for data collection and analysis. The collected data can be further used in various research methodologies. Some of the research mechanisms used in the Dibutyl Itaconate (Cas 2155-60-4) market report are the primary research mechanism and Secondary research mechanism.

Key questions answered in the report include:What will the market size and the growth rate be in 2027?What are the key factors driving the Global Dibutyl Itaconate (Cas 2155-60-4) Market?What are the key market trends impacting the growth of the Global Dibutyl Itaconate (Cas 2155-60-4) Market?What are the challenges to market growth?Who are the key vendors in the Global Dibutyl Itaconate (Cas 2155-60-4) Market?What are the market opportunities and threats faced by the vendors in the Global Dibutyl Itaconate (Cas 2155-60-4) Market?

Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamicsIt provides a forward looking perspective on different factors driving or restraining market growthIt provides a six-year forecast assessed on the basis of how the market is predicted to growIt helps in understanding the key product segments and their futureIt provides pin point analysis of changing competition dynamics and keeps you ahead of competitorsIt helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Make an Enquiry Before Buyingthis Report @https://www.algororeports.com/checkout?currency=five_user-USD&report_id=3119097

Contact Us:

Sanjay JainManager Partner Relations & International MarketingPh: +1-352-353-0818 (US)Web:https://www.algororeports.com

Here is the original post:
Dibutyl Itaconate (Cas 2155-60-4) Market 2021 Global Future Growth, Leading Players and Forecast to 2027| HANERCHEM, Zhejiang Guoguang Biochemistry,...

Food Addiction: A Disorder To Watch – Outlook India

Food addiction, although controversial, has recently gained attention in scientific literature and falls into the realm of atypical eating disorders. It has been implicated in craving, bingeing and obesity. Its recognition may be useful in management of complications like diabetes, obesity, heart disease and other chronic conditions.

Food addiction implies there is a biochemical condition in the body that creates a physiological craving for specific foods. This craving, and its underlying biochemistry, is comparable to an alcoholic's craving for alcohol" (a refined carbohydrate). Just as alcohol is the substance that triggers the alcoholic's disease, there are substances that trigger a food addict's out-of-control eating.

It suggests that specific foods, especially those which are rich in fat and /sugar and/or salt are capable of promoting addiction- like behaviour and neural changes under certain conditions. These foods seem to affect the same addictive brain pathways that are influenced by alcohol and drugs.Perhaps, eating carelessly, loading up on high fat, high carbohydrate and salt can also trigger hormonal imbalance, mood swings and lethargy, ultimately leading to chronic food addiction and piled pounds. These foods although highly palatable are not addictive per se but become addictive following prolonged restriction / bingeing. These could be as diverse as refined carbohydrates, processed foods, cheese, chocolates, sugars and milk proteins. Such eating behaviour has been associated with increased risk of obesity, early weight gain, depression, anxiety, and substance abuse as well as with relapses in treatment. Relevance of food addiction may be path- breaking in the treatment of overeating and obesity, which so-far have been associated with eating disorders caused from emotional problems that could be treated by psychotherapy or counseling. While, this may be true for many individuals who have used food to manage their emotions or deal with stress, the problem is more complex for the true food addict.

The key feature of any addiction is loss of control. In food addiction, loss of control is manifested by either more frequent and / larger meals. Although anecdotal reports are abundant, few studies have been able to document addictive properties of foods meeting rigorous scientific criteria. While some may argue, that all foods are addictive, it is proposed that some foods are more addictive than others.

However, recent findings suggest that it may also be the way in which foods are consumed (e.g., alternating access and restriction) rather than their sensory (taste, smell etc.) properties that leads to an addictive eating pattern. In other words, palatable foods alone are not responsible, because even non-palatable foods can come to be desired and potentially overconsumed.

In animal studies, withdrawal from high fat diets leads to neuro-chemical changes like those induced by withdrawal from drugs. There is also convincing evidence that bingeing on sugar induces behaviour and neural changes similar to those induced by drugs. Studies have further revealed that external stimuli such as cues, good or great smelling, looking, tasting, and reinforcing food stimulate seeking that food and modifying intake similar to that of drugs of abuse.

Recognising and identifying food addiction may help treatment modalities for chronic food cravings, compulsive overeating, and binge eating that may represent a phenotype of obesity. Screening for food addiction has the potential to identify people with eating difficulties that seriously compromise weight management efforts. Future research should include a focus on human food addiction.

Ms. Ishi Khosla is a practicing clinical nutritionist, columnist, author, an entrepreneur and researcher.

She is actively involved in clinical practice at the Centre for Dietary Counseling in Delhi, where she deals with a wide range of nutrition related health problems including obesity, diabetes, cardio-vascular disease, digestive disorders, food allergies etc. To scale up her practice and reach out to a global audience Ms. Khosla has founded a unique score-based nutrition app, which has helped people across the world to not only lose weight scientifically but also understand the science and art of eating right.

Passionate about nutrition and a strong believer in the power of foods, she spearheaded, the first of its kind, a health food company in India 'Whole Foods', in the business of producing and retailing health foods and operating Health Cafe's.

As part of her commitment towards public health and community nutrition, Ms. Khosla founded 'The Celiac Society Of India', the first of its kind in India, to spread awareness about gluten related disorders in India and Internationally. She is also involved in community service through the All India Womens Association and Delhi Commonwealth Womens Association. Ms Khosla has been listed among the 25 most powerful women in the country by the India Today Group.

See more here:
Food Addiction: A Disorder To Watch - Outlook India

UVA Discovery Suggests Potential New Treatment for Deadly Blood Cancer – University of Virginia

A drug used to treat certain advanced breast cancers may offer a new treatment option for a deadly blood cancer known as myelofibrosis, new research from UVA Cancer Center suggests.

The drug, palbociclib, may be able to prevent the scarring of bone marrow that existing treatments for myelofibrosis cannot. This scarring disrupts the marrows production of blood cells and causes severe anemia that leaves patients weak and fatigued. The scarring also reduces the number of platelets in the blood, making clotting difficult, and often causes an enlarged spleen.

Current therapies only provide symptomatic relief without offering significant improvement of bone marrow fibrosis. So, there is a critical need to develop more effective therapy for myelofibrosis, said senior researcher Golam Mohi of the University of Virginia School of Medicines Department of Biochemistry and Molecular Genetics. We have identified CDK6, a regulator of cell cycle, as a new therapeutic target in myelofibrosis. We demonstrate that CDK4/6 inhibitor palbociclib, in combination with ruxolitinib, markedly inhibits myelofibrosis, suggesting this drug combination could be an effective therapeutic strategy against this devastating blood disorder.

Myelofibrosis is a form of leukemia. It occurs in approximately 1 to 1.5 of every 100,000 people, primarily those who are middle-aged or older. Patients with intermediate or high-risk cases typically survive only 16 to 35 months.

Existing treatments for myelofibrosis do not address the bone marrow scarring that is a hallmark of the disease. The drug ruxolitinib is used to relieve patients symptoms, but Mohis new research suggests that pairing the drug with palbociclib may make a far superior treatment.

Palbociclib, by itself, reduced bone marrow scarring in two different mouse models of myelofibrosis. It also decreased the abnormally high levels of white blood cells seen in myelofibrosis and shrank the mices enlarged spleens.

Combining the drug with ruxolitinib offered even more benefits, restoring the bone marrow and white blood cell counts to normal and dramatically reducing the size of the mices enlarged spleens.

Additional research is needed to determine if the findings will hold true in human patients, but Mohi and his team are hopeful. They note that palbociclib is known to quiet the activity of bone marrow in patients with metastatic breast cancer (cancer that has spread to other parts of the body), and they hope there will be beneficial effects in patients with myelofibrosis.

A combinatorial therapeutic approach involving palbociclib and ruxolitinib will enable lowering the doses of each of the inhibitors and thus reducing toxicities while enhancing the therapeutic efficacy, they write in a new scientific paper outlining their findings.

New treatments for myelofibrosis are particularly needed because ruxolitinib treatment does not offer significant reduction in bone marrow fibrosis and often loses its effectiveness with prolonged use, the researchers note.

The findings from this study are very exciting, and they support the clinical investigation of palbociclib and ruxolitinib combination in patients with myelofibrosis, Mohi said.

Mohi and his team havepublished their findings in the journal Cancer Research. The research team consisted of Avik Dutta, Dipmoy Nath, Yue Yang, Bao T. Le and Golam Mohi.

The work was supported by the National Institutes of Health grants R01 HL095685, R01 HL149893 and R21 CA235472.

To keep up with the latest medical research news from UVA, subscribe to theMaking of Medicineblog.

Continued here:
UVA Discovery Suggests Potential New Treatment for Deadly Blood Cancer - University of Virginia

Resilient researchers: UW-La Crosse students adapt their research amid COVID-19 – University of Wisconsin System

Nico Lang and Cullen Schull, both May 2021 graduates, found success adapting their biochemistry research amid COVID-19.

A pair of UW-La Crosse biochemistry students didnt let COVID-19 stand in the way of their research.

Cullen Schull and Nico Lang, who each graduated with abachelors degree in biochemistryin May, had spent the past couple years researching greener routes of synthesis for high-purity curcumin, a powdery orange chemical produced by certain plants. Curcumin, the active ingredient in turmeric, has been used as a cooking ingredient and alternative medicine for centuries but also has numerous biological applications as a wonder drug.

Lang had been working on the synthesis and isolation of curcumin compounds using a green methodology and microwave energy. Typical industrial synthesis and isolation procedures are based on a report from the 1960s, taking a greater toll on the environment.

Unable to work in the lab due to COVID-19, Lang demonstrated the effectiveness of his greener approach using recently developed software the Environmental Assessment Tool for Organic Synthesis. He also completed a bibliography on the synthesis of curcumin and similar chemicals, placing his green methodology in perspective.

Schull had been working on a combinatory study to develop a simple and versatile method to obtain curcuminoids (analogues of curcumin) using a blend of synthetic and computational modeling.

From a biomedical standpoint, curcuminoids are shown to be even more effective than curcumin. However, a lack of knowledge about curcuminoid synthesis has resulted in a limited commercial availability of curcuminoids, as well as high prices.

Schulls synthetic work was put on hold during COVID-19. Instead, he used molecular modeling to better understand the mechanism of curcuminoid synthesis, gaining valuable data and experience conducting online research.

This summer, Schull is finishing his project and hoping to publish his manuscript.

His work helped earn a WiSys Spark grant, which was funded for the spring 2021 semester and summer 2021.

It is particularly remarkable that these two students felt the substantial impact of COVID-19 on their research but were able to use the forced online transition as an opportunity to take their research to a new level, saysValeria Stepanova, an assistant professor of chemistry and biochemistry and the students research advisor.

Lang has been accepted into the University of Utahs graduate chemistry program. Schull plans to pursue a doctorate in organic chemistry at Northwestern University.

See more here:
Resilient researchers: UW-La Crosse students adapt their research amid COVID-19 - University of Wisconsin System

What We Think We Know About Metabolism May Be Wrong – The New York Times

Everyone knows conventional wisdom about metabolism: People put pounds on year after year from their 20s onward because their metabolisms slow down, especially around middle age. Women have slower metabolisms than men. Thats why they have a harder time controlling their weight. Menopause only makes things worse, slowing womens metabolisms even more.

All wrong, according to a paper published Thursday in Science. Using data from nearly 6,500 people, ranging in age from 8 days to 95 years, researchers discovered that there are four distinct periods of life, as far as metabolism goes. They also found that there are no real differences between the metabolic rates of men and women after controlling for other factors.

The findings from the research are likely to reshape the science of human physiology and could also have implications for some medical practices, like determining appropriate drug doses for children and older people.

It will be in textbooks, predicted Leanne Redman, an energy balance physiologist at Pennington Biomedical Research Institute in Baton Rouge, La., who also called it a pivotal paper.

Rozalyn Anderson, a professor of medicine at the University of Wisconsin-Madison, who studies aging, wrote a perspective accompanying the paper. In an interview, she said she was blown away by its findings. We will have to revise some of our ideas, she added.

But the findings implications for public health, diet and nutrition are limited for the moment because the study gives a 30,000-foot view of energy metabolism, said Dr. Samuel Klein, who was not involved in the study and is director of the Center for Human Nutrition at the Washington University School of Medicine in St. Louis. He added, I dont think you can make any new clinical statements for an individual. When it comes to weight gain, he says, the issue is the same as it has always been: People are eating more calories than they are burning.

Metabolic research is expensive, and so most published studies have had very few participants. But the new studys principal investigator, Herman Pontzer, an evolutionary anthropologist at Duke University, said that the projects participating researchers agreed to share their data. There are more than 80 co-authors on the study. By combining efforts from a half dozen labs collected over 40 years, they had sufficient information to ask general questions about changes in metabolism over a lifetime.

All of the research centers involved in the project were studying metabolic rates with a method considered the gold standard doubly labeled water. It involves measuring calories burned by tracking the amount of carbon dioxide a person exhales during daily activities.

The investigators also had participants heights and weights and percent body fat, which allowed them to look at fundamental metabolic rates. A smaller person will burn fewer calories than a bigger person, of course, but correcting for size and percent fat, the group asked, Were their metabolisms different?

It was really clear that we didnt have a good handle on how body size affects metabolism or how aging affects metabolism, Dr. Pontzer said. These are basic fundamental things youd think would have been answered 100 years ago.

Central to their findings was that metabolism differs for all people across four distinct stages of life.

Theres infancy, up until age 1, when calorie burning is at its peak, accelerating until it is 50 percent above the adult rate.

Then, from age 1 to about age 20, metabolism gradually slows by about 3 percent a year.

From age 20 to 60, it holds steady.

And, after age 60, it declines by about 0.7 percent a year.

Once the researchers controlled for body size and the amount of muscle people have, they also found no differences between men and women.

As might be expected, while the metabolic rate patterns hold for the population, individuals vary. Some have metabolic rates 25 percent below the average for their age and others have rates 25 percent higher than expected. But these outliers do not change the general pattern, reflected in graphs showing trajectory of metabolic rates over the years.

The four periods of metabolic life depicted in the new paper show there isnt a constant rate of energy expenditure per pound, Dr. Redman noted. The rate depends on age. That runs counter to the longstanding assumptions she and others in nutrition science held.

The trajectories of metabolism over the course of a lifetime and the individuals who are outliers will open a number of research questions. For instance, what are the characteristics of people whose metabolisms are higher or lower than expected, and is there a relationship with obesity?

One of the findings that most surprised Dr. Pontzer was the metabolism of infants. He expected, for example, that a newborn infant would have a sky-high metabolic rate. After all, a general rule in biology is that smaller animals burn calories faster than larger ones.

Instead, Dr. Pontzer said, for the first month of life, babies have the same metabolic rate as their mothers. But shortly after a baby is born, he said, something kicks in and the metabolic rate takes off.

The group also expected the metabolism of adults to start slowing when they were in their 40s or, for women, with the onset of menopause.

But, Dr. Pontzer said, we just didnt see that.

The metabolic slowing that starts around age 60 results in a 20 percent decline in the metabolic rate by age 95.

Dr. Klein said that although people gain on average more than a pound and a half a year during adulthood, they can no longer attribute it to slowing metabolisms.

Energy requirements of the heart, liver, kidney and brain account for 65 percent of the resting metabolic rate although they constitute only 5 percent of body weight, Dr. Klein said. A slower metabolism after age 60, he added, may mean that crucial organs are functioning less well as people age. It might be one reason that chronic diseases tend to occur most often in older people.

Even college students might see the effects of the metabolic shift around age 20, Dr. Klein said. When they finish college they are burning fewer calories than when they started.

And around age 60, no matter how young people look, they are changing in a fundamental way.

There is a myth of retaining youth, Dr. Anderson said. Thats not what the biology says. In and around age 60, things start to change.

There is a time point when things are no longer as they used to be.

See the article here:
What We Think We Know About Metabolism May Be Wrong - The New York Times

Telehealth enabled NASA to care for astronauts in orbit, but agency is eyeing the moon and beyond – Healthcare Finance News

Dr. Shannan Moynihan, left, and Michelle Frieling of NASA speak during the HIMSS21 conference in Las Vegas on Wednesday.

Photo: Jeff Lagasse/Healthcare Finance News

LAS VEGAS - Space: It's the final frontier not just for humans, but telehealth as well.

The benefits of telehealth have become widely known here on Earth, and it's been an increasingly accepted treatment modality for patients during the pandemic. Remote virtual care has been a lifeline for scores of people with their feet planted on the ground.

But it's also become a lifeline for astronauts inside the International Space Station, and in some ways, low-Earth orbit has been ground zero for telehealth. NASA began treating space-goers remotely as early as 2002, a necessity given that astronauts are uniquely isolated from the world. The lessons learned in that time will be a launchpad for the future as NASA contemplates sending humans beyond low-Earth orbit, and further into the depths of the solar system.

Michelle Frieling, program manager for human health and performance contract at NASA, and Dr. Shannan Moynihan, deputy chief medical officer at the NASA Lyndon B. Johnson Space Center, were on hand at HIMSS21 in Las Vegas to talk about that future in their session, "Caring for Astronauts in Space: NASA's Experience With Telemedicine."

Of course, the treatment of people in space looks a bit different than the terrestrial version, since astronauts experience maladies that are unique to space travel. In addition to the usual sicknesses and injuries that can occur on Earth, these astronaut-specific conditions are linked to the adaptations the body makes in response to low-gravity environments.

"We send up very healthy people," said Moynihan. "That's always the goal. (But) normal physiology is being put into an abnormal environment. It works well while you're up there, but when you come back, those adaptive changes are not always a positive thing."

One of the big adaptive changes that can occur is SANS, or Spaceflight Associated Neuro-ocular Syndrome, an optic disc anemia that can cause temporary vision issues among people who have been on prolonged space missions.

"We don't have a corollary here on Earth," said Moynihan. "It teaches us a lot about the physiology that happens here in space, and my hope is that it helps us understand physiological issues here on Earth."

Other issues include neurovestibular ailments, which can affect an astronaut's balance and posture, causing them to sway while walking when they're back on solid ground. It's a condition that can last for up to two weeks after returning from a flight. Then there are fluid shifts, in which the body's fluids, generally pulled toward the feet by gravity, settle instead around the chest and head. Not a problem for those in space, but certainly an issue for the newly earthbound.

How to treat those conditions, or any other, when a human being is 250 nautical miles away?

Ultrasound machines are the primary imaging devices used on the ISS, according to Frieling. With no CT or MRI machines, the ultrasound machines are used in novel ways, able to give clinically relevant exams in space with the ability to send that information to people on the ground.

These people on the ground who NASA refers to as "remote guiders" are the key. In most other respects, telehealth in space looks like telehealth on the ground: video or audio encounters in which a patient consults with a medical expert. What the remote guiders do is direct astronauts through procedures, in layman's terms, to ensure that clinical robust data is being collected and relevant procedures performed aboard the space station.

"We don't always have a physician on board the space station," said Frieling. "So we're asking somebody who's had maybe 45 minutes of training on the ultrasound device and asking them to get clinically relevant results while learning other stuff too, like ISS systems and the science experiments and activities they're going to do. The remote guiders come in. They walk the crew through various procedures. They're on the ground talking to the crew in real time in order to get the images we need on the ground for clinical diagnoses, or research studies as well."

Ophthalmologists and other specialists examine the data as it's coming down and give tips and techniques to the remote guiders. An important thing for the remote guiders to consider is their own disposition. Since many of these interactions take place via video, the crew onboard the ISS can pick up on smiles and frowns, and these indicators of a person's mood can have an effect on those traversing the vacuum of space.

What telehealth does, essentially, is free astronauts from having to undergo hours of medical training. Instead, they can focus their time and attention on the mission.

Equipment considerations are unique, though, since there's a lot of planning and logistics involved in certifying a medical device to be flown up to the space station. Data needs have to be considered carefully, as well as the compatibility with other devices and technology aboard the ISS. Since the space station is a closed environment, crews have to take into account how something like an ultrasound machine will affect the atmosphere.

For now, the telehealth approach works well as intended. But there are future challenges. Low-Earth orbit is one thing, but plans are already underway to land the first woman and the first person of color on the moon. Beyond that, humanity is eyeing Mars, a mission that could take an astronaut into space for as long as three years.

That will result not only in significant physiological changes for the astronauts, but a rethinking of how telehealth communication will take place. The further away from the planet a crew is, the longer it takes to send and receive data, meaning communications will no longer be in real time.

These will be challenges, but NASA understands these issues and has a rough game plan for how to address them.

"We're going to think about how we do these medical conferences very differently," said Frieling. "We need to develop things like software systems that help make diagnosis and treatment decisions for the crew. We need real-time training videos. We really need an integrated architecture that provides us with advanced analytics so we can put the power in the crew's hands."

Twitter:@JELagasseEmail the writer:jeff.lagasse@himssmedia.com

Read more here:
Telehealth enabled NASA to care for astronauts in orbit, but agency is eyeing the moon and beyond - Healthcare Finance News

Policing the Bodies of Women Athletes Is Nothing New – JSTOR Daily

In 1891, Dr. James Naismith invented the game of basketball. A year later, physical education teacher Senda Berenson Abbott of Smith College decided to adapt the game for the nineteenth-century woman, complete with a set of modified rules. Each player was confined to a small zone on the court. She was not allowed to bounce the ball more than three times. Otherwise, she might risk overexerting herselfor potentially dislodging her uterus.

Anxiety about female exercise is at least a century old in the United States, writes historian Martha Verbrugge. The early twentieth century saw the emergence of a new culture of active womanhood. Organized sports flourished in blue-collar industries, nonwhite communities, and some Black colleges and training schools. Schools introduced mandatory physical education. Upper- and middle-class white women regularly took part in non-competitive mixed-gender recreation.

During this time, there was also a growing interest in the science of exercise. Researchers from the fields of physiology, biomechanics, clinical medicine, and physical educationwhom Verbrugge refers to as body expertsanalyzed physical activity and applied that knowledge in everyday settings. Without pause, Verbrugge writes, these experts assumed that sex was a relevant factor, even the primary one, in the relationships between anatomy, physiology, movement, and skill, as well as an individuals attitudes during play or competition.

And, in the grand tradition of scientific essentialism, these experts immediately homed in on the uterus. Body experts regarded reproductive systems as the most salient difference between males and females, Verbrugge writes. But they struggled to reach consensus, as every frantic report of menstrual dysfunction, miscarriage and even sterility attributed to exercise and sports was countered by equally fervent claims that physical activity during menstruation was safe, even beneficial, and that athletic women experienced normal pregnancies.

In the early 1900s, intense exercise was thought to put young women at risk of infertility. Physical education teachers taught young girls to be active within the limits of their fragile form. No teacher doubted that strenuous exercise during menstruation was risky, writes Verbrugge. Or, conversely, that a womans period limited her physical vitality and skill.

The latter half of the twentieth century saw a fitness and sports boom in the United States. The science of fitness had become a veritable cottage industry. Specialists warned about new health problems associated with exercise and training. In the 1980s and 90s, concerns about menstrual irregularities, like athletic amenorrhoea, escalated sharply. The roster of suspect activities and high-risk females now included skiers, rowers, fencers, volleyball players, and even occasional joggers, writes Verbrugge.

These new anxieties also extended to pregnancy and childbirth, as well as non-reproductive health, writes Verbrugge. Scientists observed the co-morbidity of eating disorders, premature osteoporosis and amenorrhoea among young athletes. In 1992, the American College of Sports Medicine labeled these three conditions the Female Athlete Triad.

Even during the 2020 Olympics, the most gender-balanced games in history, the bodies of elite athletes were still subject to intense scrutiny (especially the bodies of Black women athletes). One might assume that doubts about female exercise persisted because scientific analysis remained ambiguous or incomplete, writes Verbrugge. In reality, she argues, these concerns are rooted more in cultural developments than in biomedical discoveries.

Support JSTOR Daily! Join our new membership program on Patreon today.

JSTOR is a digital library for scholars, researchers, and students. JSTOR Daily readers can access the original research behind our articles for free on JSTOR.

By: H. Grace Shymanski

Indiana Magazine of History, Vol. 114, No. 1 (March 2018), pp. 39-59

Indiana University Press

By: Martha H. Verbrugge

Health and History, Vol. 4, No. 1 (2002), pp. 52-72

Australian and New Zealand Society of the History of Medicine, Inc

Read more:
Policing the Bodies of Women Athletes Is Nothing New - JSTOR Daily